Atrial Fibrillation, Venous Thromboembolism, and Risk of Pulmonary Hypertension: A Swedish Nationwide Register Study
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.037418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Clara Hjalmarsson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Sahlgrenska University Hospital Gothenburg Sweden. Hauptthemen laut MEDLINE: Atrial Fibrillation, Venous Thromboembolism, Hypertension, Pulmonary. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) is suggested to be associated with venous thromboembolism (VTE) and might thereby play a role in the development of chronic thromboembolic pulmonary hypertension (PH). By elevating left‐sided filling pressure and promoting atrial myopathy, AF may also play a role in the development of postcapillary PH. We aimed to investigate the association between AF, with or without incident VTE, and the occurrence of PH.
Methods
A total of 521 988 patients diagnosed with AF between 1987 and 2013, without a previous diagnosis of VTE or PH, were identified from the Swedish National Patient Register and matched for age, sex, and county with 1 017 277 population controls without AF, VTE, or PH.
Results
The mean age of the patients with AF was 71.1 (SD ±10.1) years and 42.8% were women. During a median follow‐up period of 11 (interquartile range 5.1–17) years, 4454 (0.9%) patients with AF, and 1855 (0.2%) controls were diagnosed with PH, hazard ratio 4.7 (4.4–5.0). The AF group had a significantly higher comorbidity burden at baseline, with a mean CHA 2 DS 2 ‐VASc of 2.9 compared with 2.1 in controls. In the absence of intercurrent VTE, the hazard ratio of PH was 4.2 (3.9–4.5) among patients with AF compared with controls. Intercurrent VTE increased the hazard ratio of PH a further 1.9‐fold (1.7–2.1) and 3.5 (3.1–4.0), among patients with AF and controls, respectively. The hazard ratio for PH in patients with AF with incident VTE was 8.1 (7.3–9.1).
Conclusions
AF was associated with a markedly increased risk of developing incident PH, and this risk was further increased by incident VTE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology Sahlgrenska University Hospital Gothenburg Sweden.
- Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
- Department of Medicine, Geriatrics and Emergency Medicine Sahlgrenska University Hospital/Östra Gothenburg Sweden.
- Department of Cardiology, Clinical Sciences Lund University and Skåne University Hospital Lund Sweden.
- Wallenberg Center for Molecular Medicine and Lund University Diabetes Center Lund University Lund Sweden.
- School of Public Health and Community Medicine, Health Metrics Unit University of Gothenburg Gothenburg Sweden.
ORCID-Profile: Clara Hjalmarsson, Martin Lindgren, Niklas Bergh, Martin Adiels, Annika Rosengren
Zitieren
APA
Hjalmarsson, C., Lindgren, M., Bergh, N., Hornestam, B., Smith, J. G., Adiels, M., & Rosengren, A. (2025). Atrial Fibrillation, Venous Thromboembolism, and Risk of Pulmonary Hypertension: A Swedish Nationwide Register Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.037418
Vancouver
Hjalmarsson C, Lindgren M, Bergh N, Hornestam B, Smith JG, Adiels M, et al. Atrial Fibrillation, Venous Thromboembolism, and Risk of Pulmonary Hypertension: A Swedish Nationwide Register Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.037418
BibTeX
@article{Hjalmarsson2025,
author = {Hjalmarsson, Clara and Lindgren, Martin and Bergh, Niklas and Hornestam, Björn and Smith, J G and Adiels, Martin and Rosengren, Annika},
title = {Atrial Fibrillation, Venous Thromboembolism, and Risk of Pulmonary Hypertension: A Swedish Nationwide Register Study},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.037418}
}
EUVIMED